 | • レポートコード：MRC2302E0125 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、248ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥692,860 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,392,860 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に149.2億ドルであった世界の動物健康用API市場規模が、2022年に161.1億ドルになり、2027年まで年平均8.12%で成長して238.4億ドルに達すると予測しています。本レポートでは、動物健康用APIの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、ビジネス別（キャプティブAPI、マーチャントAPI）分析、疾患別（抗感染症薬、抗寄生虫薬、非ステロイド性抗炎症薬＆麻酔薬）分析、合成別（バイオテクノロジー、合成）分析、種類別（ブランド、ジェネリック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、本書には、Blanver Farmoquimica E Farmaceutica S.A.、Changzhou Yabang-Qh Pharmachem Co., Ltd.、Eli Lilly & Co.、Excel Industries Ltd.、Glenmark Pharmaceutical Ltd.、Huvepharma、Indukern, S.A.、Lonza Group AG、NGL Fine Chem Ltd.、Ningxia Tairui Pharma CO. Ltd.、Ofichem BVなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の動物健康用API市場規模：ビジネス別 - キャプティブAPIの市場規模 - マーチャントAPIの市場規模 ・世界の動物健康用API市場規模：疾患別 - 抗感染症薬における市場規模 - 抗寄生虫薬における市場規模 - 非ステロイド性抗炎症薬＆麻酔薬における市場規模 ・世界の動物健康用API市場規模：合成別 - 動物健康用バイオテクノロジーAPIにおける市場規模 - 動物健康用合成APIにおける市場規模 ・世界の動物健康用API市場規模：種類別 - ブランドにおける市場規模 - ジェネリックにおける市場規模 ・世界の動物健康用API市場規模：地域別 - 南北アメリカの動物健康用API市場規模 アメリカの動物健康用API市場規模 カナダの動物健康用API市場規模 ブラジルの動物健康用API市場規模 ... - アジア太平洋の動物健康用API市場規模 日本の動物健康用API市場規模 中国の動物健康用API市場規模 インドの動物健康用API市場規模 韓国の動物健康用API市場規模 台湾の動物健康用API市場規模 ... -ヨーロッパ/中東/アフリカの動物健康用API市場規模 イギリスの動物健康用API市場規模 ドイツの動物健康用API市場規模 フランスの動物健康用API市場規模 ロシアの動物健康用API市場規模 ... -その他地域の動物健康用API市場規模 ・競争状況 ・企業情報 |
The Global Animal Health Active Pharmaceutical Ingredients Market size was estimated at USD 14.92 billion in 2021 and expected to reach USD 16.11 billion in 2022, and is projected to grow at a CAGR 8.12% to reach USD 23.84 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Animal Health Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Business, the market was studied across Captive API and Merchant API.
Based on Indication, the market was studied across Anti-infectives, Antiparasitics, and NSAIDs & Anesthetics.
Based on Synthesis, the market was studied across Biotech and Synthetic.
Based on Type, the market was studied across Branded and Generic.
Based on End User, the market was studied across Pet Care Hospitals and Retail and specialty pharmacies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Animal Health Active Pharmaceutical Ingredients market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Health Active Pharmaceutical Ingredients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Health Active Pharmaceutical Ingredients Market, including Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Ltd., Glenmark Pharmaceutical Ltd., Huvepharma, Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ningxia Tairui Pharma CO. Ltd., Ofichem BV, Omkar Speciality Chemicals Limited, ouro fino saude animal, P&R SpA (Olon SpA), Sanofi Winthrop Industrie (CEPiA), Sequent Scientific Ltd., Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shanghai Pharmtech Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Animal Health Active Pharmaceutical Ingredients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Health Active Pharmaceutical Ingredients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Health Active Pharmaceutical Ingredients Market?
4. What is the competitive strategic window for opportunities in the Global Animal Health Active Pharmaceutical Ingredients Market?
5. What are the technology trends and regulatory frameworks in the Global Animal Health Active Pharmaceutical Ingredients Market?
6. What is the market share of the leading vendors in the Global Animal Health Active Pharmaceutical Ingredients Market?
7. What modes and strategic moves are considered suitable for entering the Global Animal Health Active Pharmaceutical Ingredients Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of pets across the globe
5.1.1.2. Increasing awareness and expenditure among people regarding the animal healthcare
5.1.1.3. Significant growth in the number of animal healthcare NGOs
5.1.2. Restraints
5.1.2.1. Several risk factors associated with animal health APIs
5.1.3. Opportunities
5.1.3.1. Development of new products
5.1.3.2. Unmet animal needs in many countries
5.1.4. Challenges
5.1.4.1. Limited awareness and availability in low-income areas
5.2. Cumulative Impact of COVID-19
6. Animal Health Active Pharmaceutical Ingredients Market, by Business
6.1. Introduction
6.2. Captive API
6.3. Merchant API
7. Animal Health Active Pharmaceutical Ingredients Market, by Indication
7.1. Introduction
7.2. Anti-infectives
7.3. Antiparasitics
7.4. NSAIDs & Anesthetics
8. Animal Health Active Pharmaceutical Ingredients Market, by Synthesis
8.1. Introduction
8.2. Biotech
8.3. Synthetic
9. Animal Health Active Pharmaceutical Ingredients Market, by Type
9.1. Introduction
9.2. Branded
9.3. Generic
10. Animal Health Active Pharmaceutical Ingredients Market, by End User
10.1. Introduction
10.2. Pet Care Hospitals
10.3. Retail and specialty pharmacies
11. Americas Animal Health Active Pharmaceutical Ingredients Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Animal Health Active Pharmaceutical Ingredients Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Animal Health Active Pharmaceutical Ingredients Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Blanver Farmoquimica E Farmaceutica S.A.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Changzhou Yabang-Qh Pharmachem Co., Ltd.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Eli Lilly & Co.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Excel Industries Ltd.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Glenmark Pharmaceutical Ltd.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Huvepharma
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Indukern, S.A.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Lonza Group AG
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. NGL Fine Chem Ltd.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Ningxia Tairui Pharma CO. Ltd.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Ofichem BV
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Omkar Speciality Chemicals Limited
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. ouro fino saude animal
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. P&R SpA (Olon SpA)
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Sanofi Winthrop Industrie (CEPiA)
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Sequent Scientific Ltd.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Shanghai Pharmtech Co. Ltd.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Zhejiang Hisun Pharmaceutical Co. Ltd
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Zoetis Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing